{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:32:56Z","timestamp":1791156776415,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007202","name":"Gouvernement du Canada | Instituts de Recherche en Sant\u00e9 du Canada | CIHR Skin Research Training Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41386-021-00974-y","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T02:10:49Z","timestamp":1612231849000},"page":"920-927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Increased functional coupling of the mu opioid receptor in the anterior insula of depressed individuals"],"prefix":"10.1038","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3383-1604","authenticated-orcid":false,"given":"Pierre-Eric","family":"Lutz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Filliol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Jollant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8809-8334","authenticated-orcid":false,"given":"Brigitte L.","family":"Kieffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-2736","authenticated-orcid":false,"given":"Gustavo","family":"Turecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"974_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","volume":"36","author":"PE Lutz","year":"2013","unstructured":"Lutz PE, Kieffer BL. Opioid receptors: distinct roles in mood disorders. Trends Neurosci. 2013;36:195\u2013206.","journal-title":"Trends Neurosci"},{"key":"974_CR2","doi-asserted-by":"publisher","unstructured":"Nummenmaa L, Karjalainen T, Isoj\u00e4rvi J, Kantonen T, Tuisku J, Kaasinen V, et al. Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety. Neuropsychopharmacology. 2020. https:\/\/doi.org\/10.1038\/s41386-020-0725-9.","DOI":"10.1038\/s41386-020-0725-9"},{"key":"974_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1126\/science.1060952","volume":"293","author":"JK Zubieta","year":"2001","unstructured":"Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001;293:311\u20135.","journal-title":"Science"},{"key":"974_CR4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/archpsyc.60.11.1145","volume":"60","author":"JK Zubieta","year":"2003","unstructured":"Zubieta JK, Ketter TA, Bueller JA, Xu Y, Kilbourn MR, Young EA, et al. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry. 2003;60:1145\u201353.","journal-title":"Arch Gen Psychiatry"},{"key":"974_CR5","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1001\/archpsyc.63.11.1199","volume":"63","author":"SE Kennedy","year":"2006","unstructured":"Kennedy SE, Koeppe RA, Young EA, Zubieta JK. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry. 2006;63:1199\u2013208.","journal-title":"Arch Gen Psychiatry"},{"key":"974_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tins.2017.02.002","volume":"40","author":"H Namkung","year":"2017","unstructured":"Namkung H, Kim S-H, Sawa A. The insula: an underestimated brain area in clinical neuroscience, psychiatry, and neurology. Trends Neurosci. 2017;40:200\u20137.","journal-title":"Trends Neurosci"},{"key":"974_CR7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/mp.2013.96","volume":"18","author":"DT Hsu","year":"2013","unstructured":"Hsu DT, Sanford BJ, Meyers KK, Love TM, Hazlett KE, Wang H, et al. Response of the mu-opioid system to social rejection and acceptance. Mol Psychiatry. 2013;18:1211\u20137.","journal-title":"Mol Psychiatry"},{"key":"974_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/mp.2014.185","volume":"20","author":"DT Hsu","year":"2015","unstructured":"Hsu DT, Sanford BJ, Meyers KK, Love TM, Hazlett KE, Walker SJ, et al. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder. Mol Psychiatry. 2015;20:193\u2013200.","journal-title":"Mol Psychiatry"},{"key":"974_CR9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.biopsych.2019.03.965","volume":"86","author":"PA Spagnolo","year":"2019","unstructured":"Spagnolo PA, Kimes A, Schwandt ML, Shokri-Kojori E, Thada S, Phillips KA, et al. Striatal dopamine release in response to morphine: a [11C]Raclopride positron emission tomography study in healthy men. Biol Psychiatry. 2019;86:356\u201364.","journal-title":"Biol Psychiatry"},{"key":"974_CR10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00702-004-0239-3","volume":"112","author":"G Zalsman","year":"2005","unstructured":"Zalsman G, Molcho A, Huang Y, Dwork A, Li S, Mann JJ. Postmortem mu-opioid receptor binding in suicide victims and controls. J Neural Transm. 2005;112:949\u201354.","journal-title":"J Neural Transm"},{"key":"974_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/sj.mp.4000727","volume":"5","author":"JJ Meana","year":"2000","unstructured":"Meana JJ, Gonzalez-Maeso J, Garcia-Sevilla JA, Guimon J. mu-opioid receptor and alpha2-adrenoceptor agonist stimulation of [35S]GTPgammaS binding to G-proteins in postmortem brains of opioid addicts. Mol Psychiatry. 2000;5:308\u201315.","journal-title":"Mol Psychiatry"},{"key":"974_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0006-8993(90)91301-V","volume":"530","author":"R Gross-Isseroff","year":"1990","unstructured":"Gross-Isseroff R, Dillon KA, Israeli M, Biegon A. Regionally selective increases in mu opioid receptor density in the brains of suicide victims. Brain Res. 1990;530:312\u20136.","journal-title":"Brain Res"},{"key":"974_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0006-8993(95)00333-L","volume":"682","author":"AM Gabilondo","year":"1995","unstructured":"Gabilondo AM, Meana JJ, Garcia-Sevilla JA. Increased density of mu-opioid receptors in the postmortem brain of suicide victims. Brain Res. 1995;682:245\u201350.","journal-title":"Brain Res"},{"key":"974_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-12-126","volume":"12","author":"E Scarr","year":"2012","unstructured":"Scarr E, Money TT, Pavey G, Neo J, Dean B. Mu opioid receptor availability in people with psychiatric disorders who died by suicide: a case control study. BMC Psychiatry. 2012;12:126.","journal-title":"BMC Psychiatry"},{"key":"974_CR15","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1176\/appi.ajp.162.11.2116","volume":"162","author":"A Dumais","year":"2005","unstructured":"Dumais A, Lesage AD, Alda M, Rouleau G, Dumont M, Chawky N, et al. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry. 2005;162:2116\u201324.","journal-title":"Am J Psychiatry"},{"key":"974_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1600-0447.1993.tb03341.x","volume":"87","author":"DA Brent","year":"1993","unstructured":"Brent DA, Perper JA, Moritz G, Allman CJ, Roth C, Schweers J, et al. The validity of diagnoses obtained through the psychological autopsy procedure in adolescent suicide victims: use of family history. Acta Psychiatr Scand. 1993;87:118\u201322.","journal-title":"Acta Psychiatr Scand"},{"key":"974_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1034\/j.1600-0447.2001.00091.x","volume":"104","author":"KR Conner","year":"2001","unstructured":"Conner KR, Conwell Y, Duberstein PR. The validity of proxy-based data in suicide research: a study of patients 50 years of age and older who attempted suicide. II. Life events, social support and suicidal behavior. Acta Psychiatr Scand. 2001;104:452\u20137.","journal-title":"Acta Psychiatr Scand"},{"key":"974_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1600-0447.1996.tb09869.x","volume":"94","author":"TM Kelly","year":"1996","unstructured":"Kelly TM, Mann JJ. Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician ante-mortem diagnosis. Acta Psychiatr Scand. 1996;94:337\u201343.","journal-title":"Acta Psychiatr Scand"},{"key":"974_CR19","unstructured":"Mai JK, Paxinos G, Voss T. Atlas of the human brain. Academic Press Inc, 3rd ed. Elsevier Science. 2007."},{"key":"974_CR20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.biopsych.2017.07.012","volume":"84","author":"PE Lutz","year":"2018","unstructured":"Lutz PE, Gross JA, Dhir SK, Maussion G, Yang J, Bramoulle A, et al. Epigenetic regulation of the kappa opioid receptor by child abuse. Biol Psychiatry. 2018;84:751\u201361.","journal-title":"Biol Psychiatry"},{"key":"974_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1101\/gr.2754005","volume":"15","author":"S Weckx","year":"2005","unstructured":"Weckx S, Del-Favero J, Rademakers R, Claes L, Cruts M, De Jonghe P, et al. novoSNP, a novel computational tool for sequence variation discovery. Genome Res. 2005;15:436\u201342.","journal-title":"Genome Res"},{"key":"974_CR22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/sj.mp.4001067","volume":"7","author":"J Gonzalez-Maeso","year":"2002","unstructured":"Gonzalez-Maeso J, Rodriguez-Puertas R, Meana JJ, Garcia-Sevilla JA, Guimon J. Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors. Mol Psychiatry. 2002;7:755\u201367.","journal-title":"Mol Psychiatry"},{"key":"974_CR23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1176\/appi.ajp.2017.16111286","volume":"174","author":"PE Lutz","year":"2017","unstructured":"Lutz PE, Tanti A, Gasecka A, Barnett-Burns S, Kim JJ, Zhou Y, et al. Association of a history of child abuse with impaired myelination in the anterior cingulate cortex: convergent epigenetic, transcriptional, and morphological evidence. Am J Psychiatry. 2017;174:1185\u201394.","journal-title":"Am J Psychiatry"},{"key":"974_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nbt1385","volume":"26","author":"GK Geiss","year":"2008","unstructured":"Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol. 2008;26:317\u201325.","journal-title":"Nat Biotechnol"},{"key":"974_CR25","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1093\/hmg\/dds314","volume":"21","author":"BG Oertel","year":"2012","unstructured":"Oertel BG, Doehring A, Roskam B, Kettner M, Hackmann N, Ferreiros N, et al. Genetic-epigenetic interaction modulates mu-opioid receptor regulation. Hum Mol Genet. 2012;21:4751\u201360.","journal-title":"Hum Mol Genet"},{"key":"974_CR26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.conb.2013.02.005","volume":"23","author":"PE Lutz","year":"2013","unstructured":"Lutz PE, Kieffer BL. The multiple facets of opioid receptor function: implications for addiction. Curr Opin Neurobiol. 2013;23:473\u20139.","journal-title":"Curr Opin Neurobiol"},{"key":"974_CR27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.conb.2004.05.005","volume":"14","author":"C Contet","year":"2004","unstructured":"Contet C, Kieffer BL, Befort K. Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol. 2004;14:370\u20138.","journal-title":"Curr Opin Neurobiol"},{"key":"974_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1073\/pnas.1419183112","volume":"112","author":"J Xu","year":"2015","unstructured":"Xu J, Faskowitz AJ, Rossi GC, Xu M, Lu Z, Pan YX, et al. Stabilization of morphine tolerance with long-term dosing: association with selective upregulation of mu-opioid receptor splice variant mRNAs. Proc Natl Acad Sci USA. 2015;112:279\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"974_CR29","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/jnc.12768","volume":"130","author":"V Verzillo","year":"2014","unstructured":"Verzillo V, Madia PA, Liu N-J, Chakrabarti S, Gintzler AR. Mu-opioid receptor splice variants: sex-dependent regulation by chronic morphine. J Neurochem. 2014;130:790\u20136.","journal-title":"J Neurochem"},{"key":"974_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0169-328X(96)00305-1","volume":"45","author":"MP Castelli","year":"1997","unstructured":"Castelli MP, Melis M, Mameli M, Fadda P, Diaz G, Gessa GL. Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain. Brain Res Mol Brain Res. 1997;45:149\u201353.","journal-title":"Brain Res Mol Brain Res"},{"key":"974_CR31","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.biopsych.2014.08.021","volume":"77","author":"A Bilbao","year":"2015","unstructured":"Bilbao A, Robinson JE, Heilig M, Malanga CJ, Spanagel R, Sommer WH, et al. A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice. Biol Psychiatry. 2015;77:850\u20138.","journal-title":"Biol Psychiatry"},{"key":"974_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15423-5","volume":"11","author":"R Belzeaux","year":"2020","unstructured":"Belzeaux R, Gorgievski V, Fiori LM, Lopez JP, Grenier J, Lin R, et al. GPR56\/ADGRG1 is associated with response to antidepressant treatment. Nat Commun. 2020;11:1635.","journal-title":"Nat Commun"},{"key":"974_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugalcdep.2009.12.016","volume":"108","author":"SD Mague","year":"2010","unstructured":"Mague SD, Blendy JA. OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend. 2010;108:172\u201382.","journal-title":"Drug Alcohol Depend"},{"key":"974_CR34","doi-asserted-by":"publisher","first-page":"e01659","DOI":"10.1002\/brb3.1659","volume":"10","author":"S Cimino","year":"2020","unstructured":"Cimino S, Carola V, Cerniglia L, Bussone S, Bevilacqua A, Tambelli R. The \u03bc-opioid receptor gene A118G polymorphism is associated with insecure attachment in children with disruptive mood regulation disorder and their mothers. Brain Behav. 2020;10:e01659.","journal-title":"Brain Behav"},{"key":"974_CR35","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/scan\/nsr037","volume":"7","author":"A Troisi","year":"2012","unstructured":"Troisi A, Frazzetto G, Carola V, Di Lorenzo G, Coviello M, Siracusano A, et al. Variation in the mu-opioid receptor gene (OPRM1) moderates the influence of early maternal care on fearful attachment. Soc Cogn Affect Neurosci. 2012;7:542\u20137.","journal-title":"Soc Cogn Affect Neurosci"},{"key":"974_CR36","doi-asserted-by":"publisher","unstructured":"Hancock DB, Levy JL, Gaddis NC, Glasheen C, Saccone NL, Page GP, et al. Cis-expression quantitative trait loci mapping reveals replicable associations with heroin addiction in OPRM1. Biol Psychiatry. 2015. https:\/\/doi.org\/10.1016\/j.biopsych.2015.01.003.","DOI":"10.1016\/j.biopsych.2015.01.003"},{"key":"974_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0166-2236(95)93946-U","volume":"18","author":"A Mansour","year":"1995","unstructured":"Mansour A, Fox CA, Akil H, Watson SJ. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 1995;18:22\u201329.","journal-title":"Trends Neurosci"},{"key":"974_CR38","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0893-133X(01)00342-6","volume":"26","author":"J Gonzalez-Maeso","year":"2002","unstructured":"Gonzalez-Maeso J, Torre I, Rodriguez-Puertas R, Garcia-Sevilla JA, Guimon J, Meana JJ. Effects of age, postmortem delay and storage time on receptor-mediated activation of G-proteins in human brain. Neuropsychopharmacology. 2002;26:468\u201378.","journal-title":"Neuropsychopharmacology"},{"key":"974_CR39","doi-asserted-by":"publisher","first-page":"6530","DOI":"10.1074\/jbc.M807030200","volume":"284","author":"BG Oertel","year":"2009","unstructured":"Oertel BG, Kettner M, Scholich K, Renne C, Roskam B, Geisslinger G, et al. A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. J Biol Chem. 2009;284:6530\u20135.","journal-title":"J Biol Chem"},{"key":"974_CR40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1369-1600.2012.00484.x","volume":"19","author":"YJ Wang","year":"2014","unstructured":"Wang YJ, Huang P, Blendy JA, Liu-Chen LY. Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPgammaS binding in mice with Oprm1 A112G. Addict Biol. 2014;19:354\u201361.","journal-title":"Addict Biol"},{"key":"974_CR41","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/sj.npp.1300459","volume":"29","author":"PV Escriba","year":"2004","unstructured":"Escriba PV, Ozaita A, Garcia-Sevilla JA. Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacology. 2004;29:1512\u201321.","journal-title":"Neuropsychopharmacology"},{"key":"974_CR42","doi-asserted-by":"publisher","unstructured":"Lutz PE, Courtet P, Calati R. The opioid system and the social brain: implications for depression and suicide. J Neurosci Res. 2018. https:\/\/doi.org\/10.1002\/jnr.24269.","DOI":"10.1002\/jnr.24269"},{"key":"974_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03848-y","volume":"9","author":"L Nummenmaa","year":"2018","unstructured":"Nummenmaa L, Saanijoki T, Tuominen L, Hirvonen J, Tuulari JJ, Nuutila P, et al. mu-opioid receptor system mediates reward processing in humans. Nat Commun. 2018;9:1500.","journal-title":"Nat Commun"},{"key":"974_CR44","doi-asserted-by":"publisher","unstructured":"Pecina M, Karp JF, Mathew S, Todtenkopf MS, Ehrich EW, Zubieta JK. Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches. Mol Psychiatry. 2018. https:\/\/doi.org\/10.1038\/s41380-018-0117-2.","DOI":"10.1038\/s41380-018-0117-2"},{"key":"974_CR45","doi-asserted-by":"publisher","unstructured":"Eisenberger NI Social ties and health: a social neuroscience perspective. Curr Opin Neurobiol. 2013. https:\/\/doi.org\/10.1016\/j.conb.2013.01.006.","DOI":"10.1016\/j.conb.2013.01.006"},{"key":"974_CR46","doi-asserted-by":"publisher","first-page":"E9125","DOI":"10.1073\/pnas.1705753114","volume":"114","author":"DC Castro","year":"2017","unstructured":"Castro DC, Berridge KC. Opioid and orexin hedonic hotspots in rat orbitofrontal cortex and insula. Proc Natl Acad Sci USA. 2017;114:E9125\u2013E9134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"974_CR47","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrn3381","volume":"14","author":"SJ Russo","year":"2013","unstructured":"Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci. 2013;14:609\u201325.","journal-title":"Nat Rev Neurosci"},{"key":"974_CR48","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41380-018-0284-1","volume":"25","author":"M Fava","year":"2020","unstructured":"Fava M, Thase ME, Trivedi MH, Ehrich E, Martin WF, Memisoglu A, et al. Opioid system modulation with buprenorphine\/samidorphan combination for major depressive disorder: two randomized controlled studies. Mol Psychiatry. 2020;25:1580\u201391.","journal-title":"Mol Psychiatry"},{"key":"974_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1176\/appi.ajp.2015.15040535","volume":"173","author":"Y Yovell","year":"2016","unstructured":"Yovell Y, Bar G, Mashiah M, Baruch Y, Briskman I, Asherov J, et al. Ultra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: a randomized controlled trial. Am J Psychiatry. 2016;173:491\u20138.","journal-title":"Am J Psychiatry"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-021-00974-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-021-00974-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-021-00974-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:05:51Z","timestamp":1650240351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-021-00974-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["974"],"URL":"https:\/\/doi.org\/10.1038\/s41386-021-00974-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.04.325449","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"4 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}